Risk Factors for Major Thromboembolism and Bleeding Tendency after Elective General Surgical Operations

European Journal of Surgery

Volumn 162, Issue 10, 1996, Pages 783-789

  Flordal, Per Anders ^a   Bergqvist, David ^b   Burmark, Ulla Stina ^b   Ljungström, Karl Gösta ^b   Törngren, Staffan ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b NONE

Author keywords

Bleeding complication; Low molecular weight heparin; Major abdominal surgery; Multivariate analysis; Postoperative thromboembolism; Risk factors; Thrombosis prophylaxis

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING TENDENCY; DEEP VEIN THROMBOSIS; ELECTIVE SURGERY; FEMALE; GENERAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; TREATMENT OUTCOME;

ABDOMEN; ANTICOAGULANTS; DALTEPARIN; HEMORRHAGIC DISORDERS; HUMANS; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; THROMBOEMBOLISM; THROMBOPHLEBITIS;

EID: 0029905174     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford: Blackwell Scientific Publications, 1987.
2. Bergqvist D. Postoperative thromboembolism. Berlin: Springer-Verlag, 1983.
3. Bergqvist D, Burmark US, Flordal PA et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82: 496-501.
4. Bergqvist D, Mätzsch T, Jendteg S, Lindgren B, Persson U. The cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir Scand 1990; Suppl 556: 36-41.
5. Brandjes DPM, ten Cate JW, Büller HR. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively. Acta Chir Scand 1990; Suppl 556: 18-21.
6. Büller HR, Lensing AWA, Hirsh J, ten Cate JW. Deep vein thrombosis: new non-invasive diagnostic tests. Thromb Haemost 1991; 66: 133-137.
7. Clarke-Pearson DL, DeLong ER, Synan IS, Coleman RE, Creasman WT. Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol 1987; 69: 146-150.
8. Clayton JK, Anderson JA, McNicol GP. Preoperative prediction of postoperative deep vein thrombosis. BMJ 1976; ii: 910-912.
9. 125I-fibrinogen leg scanning in patients following hip surgery. Thromb Haemost 1989; 62: 830-834.
10. Eriksson BI, Kälebo P, Anthmyr BA, Wadenvik H, Tengborn L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. J Bone Joint Surg 1991; 73A: 484-493.
11. Janssen HF, Schachner J, Hubbard J, Hartman JT. The risk of deep venous thrombosis: a computerized epidemiologic approach. Surgery 1987; 101: 205-212.
12. Joint FAO/WHO/UNO Expert Consultation. Energy and protein requirements. Technical Report Series. Vol 724. Geneva: WHO, 1985.
13. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
14. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259-265.
15. Kjærgaard J, Esbensen K, Wille-Jørgensen P et al. A multivariate pattern recognition study of risk-factors indicating postoperative thromboembolism despite low-dose heparin in major abdominal surgery. Thromb Haemost 1985; 54: 409-412.
16. Lagerstedt CI, Olsson C-G, Fagher BO, Öqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985; ii: 515-518.
17. Lassen MR, Borris LC, Christiansen HM et al. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand 1991; 62: 33-38.
18. Leclerc JR, Geerts WH, Desjardins L et al. Prevention of deep vein thrombosis after major knee surgery - a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992; 67: 417-423.
19. 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost 1993; 69: 2-7.
20. Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost 1989; 62: 940-944.
21. Lowe GDO, Osborne DH, McArdle BM et al. Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery. Lancet 1982; i: 409-412.
22. Nicolaides AN, Irving D. Clinical factors and the risk of deep venous thrombosis. In: Nicolaides AN, ed. Thromboembolism. Aetiology, advances and management. Lancaster: Medical and Technical Publishing, 1975: 193-204.
23. Oster G, Tuden RL, Colditz GA. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. JAMA 1987; 257: 203-208.
24. Pezzuoli G, Serneri GGN, Settembrini P et al. Prophylaxis of fatal pulmonary embolism in general surgery using low molecular weight heparin CY216: a multicentre double-blind randomized controlled clinical trial versus placebo. Int Surg 1989; 74: 205-210.
25. Salzman EW, Davies GC. Prophylaxis of venous thromboembolism. Analysis of cost effectiveness. Ann Surg 1980; 191: 207-218.
26. Sigel B, Felix WR Jr, Justin JR et al. Prospective identification of the pulmonary embolism prone patient employing multi-variable risk factor analysis. In: Nicolaides AN, ed. Thromboembolism. Aetiology, advances and management. Lancaster: Medical and Technical Publishing, 1975: 181-191.
27. Sokal RR, Rohlf FJ. Biometry. 2nd ed. San Francisco: W. H. Freeman, 1981.
28. Sue-Ling HM, Johnston D, McMahon MJ, Philips PR, Davies JA. Pre-operative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery. Lancet 1986; i: 1173-1176.
29. Turpie AGG, Levine MN, Hirsh J et al. A randomized controlled trial of a low molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-929.
30. van Beek EJR, Tiel-van Buul MMC, Büller HR, van Royen EA, ten Cate JW. The value of lung scintigraphy in the diagnosis of pulmonary embolism. Eur J Nucl Med 1993; 20: 173-181.
31. Wille-Jørgensen P, Ott P. Predicting failure of low-dose prophylactic heparin in general surgical procedures. Surg Gynecol Obstet 1990; 171: 126-130.